FLT4 and osteosarcoma: Cediranib (AZD2171), a VEGFR family inhibitor that also blocks VEGF-C-induced VEGFR-3 activity [36], inhibits growth of pediatric sarcoma xenografts (Ewing’s-, rhabdoid- and osteosarcomas) in mice [37].